Search company, investor...
Biomet company logo

Biomet

biomet.com

Founded Year

1977

Stage

Acquired | Acquired

Valuation

$0000 

Revenue

$0000 

About Biomet

Biomet and its subsidiaries design, manufacture and market surgical and non-surgical products used primarily by orthopedic surgeons and other musculoskeletal medical specialists. Biomet's product portfolio includes hip and knee reconstructive products; sports medicine, extremities and trauma products; spine, bone healing and microfixation products; dental reconstructive products; and cement, biologics and other products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.

Headquarters Location

56 East Bell Drive

Warsaw, Indiana, 46581,

United States

574-267-6639

Missing: Biomet's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Biomet's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Biomet

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biomet is included in 2 Expert Collections, including Dental Health.

D

Dental Health

959 items

Companies delivering dental care products and services. Excludes practice networks.

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Biomet Patents

Biomet has filed 1680 patents.

The 3 most popular patent topics include:

  • Orthopedic surgical procedures
  • Implants (medicine)
  • Prosthetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/19/2021

1/24/2023

Shoulder, Muscles of the upper limb, Upper limb anatomy, Ligaments of the upper limb, Joints

Grant

Application Date

5/19/2021

Grant Date

1/24/2023

Title

Related Topics

Shoulder, Muscles of the upper limb, Upper limb anatomy, Ligaments of the upper limb, Joints

Status

Grant

Latest Biomet News

Foot And Ankle Devices Global Market Report 2022: Featuring Conmed, Medartis, Biomet, Stryker, Arthrex & More

Jan 25, 2023

The global foot and ankle devices market is expected to grow from $4.60 billion in 2021 to $5.10 billion in 2022 at a compound annual growth rate (CAGR) of 10.9%. The foot and ankle devices market is expected to grow to $6.77 billion in 2026 at a CAGR of 7.4%. The main types of products in foot and ankle devices are orthopedic implants and devices, bracing and support devices, and prostheses. A prosthesis is an artificial device that is used to replace or augment an impaired or missing part of the body This prosthesis applies to any artificial limb, regardless of whether it is an upper limb or lower limb. These are divided by the cause of injury, such as trauma, diabetes, neurological disorders, others, and are used by hospitals, ambulatory surgery centers, orthopedic clinics, rehabilitation centers, others. North America was the largest region in the foot and ankle devices market in 2021. Asia pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the foot and ankle devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The increasing rates of orthopedic disorders are expected to propel the growth of the foot and ankle devices market moving forward. Orthopedic disorders are diseases which affect the musculoskeletal system that damages the muscle and bone tissues, it includes bones, cartilage, ligaments, tendons, and connective tissues. Foot and ankle devices are used to address various types of fusions, fractures, and osteotomies in the forefoot, midfoot and rearfoot, which would increase the market growth. For instance, according to World Health Organization, a Switzerland-based government agency, musculoskeletal diseases affected 1.71 billion people worldwide in 2021, making them the major cause of disability. Apart from that, there are 568 million people who suffered from low back discomfort. Therefore, the growing incidence rates of orthopedic disorders are driving the growth of the foot and ankle devices market. Product innovations have emerged as a key trend gaining popularity in the foot and ankle market. Companies operating in the foot and ankle market are going through new product innovations to gain a competitive advantage. For instance, in September 2020, Stryker Corporation, a US-based medical technology company launched AxSOS 3 Ankle Fusion System. It is an ankle fusion titanium plate system that helps for the fusion of the tibiotalar joint. ASOS 3 Ankle Fusion System was developed with the help of Stryker's proprietary orthopedic design and development system technology. Report Attribute Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. Create regional and country strategies on the basis of local data and analysis. Identify growth segments for investment. Outperform competitors using forecast data and the drivers and trends shaping the market. Understand customers based on the latest market research findings. Benchmark performance against key competitors. Utilize the relationships between key data sets for superior strategizing. Suitable for supporting your internal and external presentations with reliable high quality data and analysis Scope

Biomet Frequently Asked Questions (FAQ)

  • When was Biomet founded?

    Biomet was founded in 1977.

  • Where is Biomet's headquarters?

    Biomet's headquarters is located at 56 East Bell Drive, Warsaw.

  • What is Biomet's latest funding round?

    Biomet's latest funding round is Acquired.

  • Who are the investors of Biomet?

    Investors of Biomet include Zimmer Biomet, Goldman Sachs, Blackstone, KKR and TPG Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.